KG

Krishna Gupta

Founder/CEO, REMUS Capital | Co-founder/Chairman, Presto | Chairman, Vyome (to be Nasdaq: HIND)

Greater Boston

Invests in

Stages:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $10,000,000.00
  • Target Investment:

    $3,000,000.00

Work Experience

  • Founder & CEO

    2008

    Remus leads Pre-Seed <> Series A rounds in Vertical AI companies, with a focus on Voice and Visual AI. We love working with maniacal rebels and have a concentrated investment approach with a focus on Building, not Betting. I founded the firm out of an MIT dorm more than a decade ago in the Great Recession. We are in the trenches with you and have brought countless million-dollar customers to our companies. https://remuscap.com/team-member/krishna-k-gupta/

2017

  • Co-founder, Chairman, & ex-CEO

    2017

    Presto is the largest American drive-thru Voice AI provider for the restaurant industry, cutting labor costs and generating revenue for its customers. Presto is expanding nationwide with several chains as the only provider combining a decade of restaurant industry experience with an LLM-native Vertical AI application that magically choreographs the dance between humans and AI. Drive-thru Voice AI is one of the most immediately scalable applications of Vertical Voice AI. While I was CEO of the predecessor company listed on the Nasdaq, the stock 4Xed in price and 10Xed in volume, with Presto becoming part of the Russell 2000 index and featured on Bloomberg TV, CNBC, the WSJ, and several other media outlets.

  • Series A lead investor

    2015

    We led the Seed and Series A out of YC; the company has grown to become one of the largest construction equipment rental companies in the US thanks to its technology platform and execution abilities.

2016

  • Chairman

    2016

    Leader in Vertical AI/analytics + embedded finance for agriculture, spun out from Stanford

  • Chairman

    2018

    Vyome is acting on a clear opportunity to leverage world-class Indian talent + cost arbitrage to tackle large US commercial opportunities in biotech and other related research-driven areas, at a time when US-India relations are on the rise. Its initial assets are targeting unmet immuno-inflammation diseases.

  • Board Member

    2016

    Leader in weight loss technology, spun out from Harvard (NYSE: $ALUR).

2013

  • Co-Founder & Board Member

    2013

    Leader in AI for Organizational Health, spun out of MIT

  • Board Member

    2015

    Leader in equipment sharing for hospitals

2018 - 2024

  • Board Member

    2018 - 2024

    Leader in compression of genomic data, spun out of Cambridge. Acquired by Storj.

2015 - 2023

  • Board Member

    2015 - 2023

    Leader in voice AI for Fortune 500 call center applications, spun out from MIT. Acquired by Verint (Nasdaq: VRNT).